| Benjamin Ross Snead, MD | |
|
3690 Grandview Pkwy Dept Of, Birmingham, AL 35243-3326 | |
| (205) 971-1257 | |
| Not Available |
| Full Name | Benjamin Ross Snead |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 10 Years |
| Location | 3690 Grandview Pkwy Dept Of, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306258751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 34347 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Baldwin Regional Medical Center | Foley, AL | Hospital |
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Thomas Hospital | Fairhope, AL | Hospital |
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Baldwin Diagnostic Imaging Associates, P.c. | 1254380769 | 4 |
News Archive
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Jonathan Waxman, a professor of oncology, was inspired to write a book by his conversations with his patients. Here, he gained insight into his patients' fears, hopes, and the impact the disease has on their lives. In The Elephant in the Room, Waxman explores the relationship of patient and specialist, how both sides deal with cancer, their interactions, and what doctors actually mean when talking to their patients.
The bacteria in your gut do more than break down your food. They also can predict susceptibility to rheumatoid arthritis, suggests Veena Taneja, Ph.D., an immunologist at Mayo Clinic's Center for Individualized Medicine. Dr. Taneja recently published two studies — one in Genome Medicine and one in Arthritis and Rheumatology — connecting the dots between gut microbiota and rheumatoid arthritis.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 7 days ago
| Entity Name | Birmingham Radiological Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376594192 PECOS PAC ID: 8022922756 Enrollment ID: O20031118000002 |
News Archive
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Jonathan Waxman, a professor of oncology, was inspired to write a book by his conversations with his patients. Here, he gained insight into his patients' fears, hopes, and the impact the disease has on their lives. In The Elephant in the Room, Waxman explores the relationship of patient and specialist, how both sides deal with cancer, their interactions, and what doctors actually mean when talking to their patients.
The bacteria in your gut do more than break down your food. They also can predict susceptibility to rheumatoid arthritis, suggests Veena Taneja, Ph.D., an immunologist at Mayo Clinic's Center for Individualized Medicine. Dr. Taneja recently published two studies — one in Genome Medicine and one in Arthritis and Rheumatology — connecting the dots between gut microbiota and rheumatoid arthritis.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 7 days ago
| Entity Name | South Baldwin Diagnostic Imaging Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124000856 PECOS PAC ID: 1254380769 Enrollment ID: O20050121000219 |
News Archive
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Jonathan Waxman, a professor of oncology, was inspired to write a book by his conversations with his patients. Here, he gained insight into his patients' fears, hopes, and the impact the disease has on their lives. In The Elephant in the Room, Waxman explores the relationship of patient and specialist, how both sides deal with cancer, their interactions, and what doctors actually mean when talking to their patients.
The bacteria in your gut do more than break down your food. They also can predict susceptibility to rheumatoid arthritis, suggests Veena Taneja, Ph.D., an immunologist at Mayo Clinic's Center for Individualized Medicine. Dr. Taneja recently published two studies — one in Genome Medicine and one in Arthritis and Rheumatology — connecting the dots between gut microbiota and rheumatoid arthritis.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Ross Snead, MD 840 Montclair Rd, Suite 317, Birmingham, AL 35213-1920 Ph: () - | Benjamin Ross Snead, MD 3690 Grandview Pkwy Dept Of, Birmingham, AL 35243-3326 Ph: (205) 971-1257 |
News Archive
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Jonathan Waxman, a professor of oncology, was inspired to write a book by his conversations with his patients. Here, he gained insight into his patients' fears, hopes, and the impact the disease has on their lives. In The Elephant in the Room, Waxman explores the relationship of patient and specialist, how both sides deal with cancer, their interactions, and what doctors actually mean when talking to their patients.
The bacteria in your gut do more than break down your food. They also can predict susceptibility to rheumatoid arthritis, suggests Veena Taneja, Ph.D., an immunologist at Mayo Clinic's Center for Individualized Medicine. Dr. Taneja recently published two studies — one in Genome Medicine and one in Arthritis and Rheumatology — connecting the dots between gut microbiota and rheumatoid arthritis.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 7 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |